November 23, 2021 -- Red Cell has formed Zephyr AI to transform drug discovery and precision medicine through the integration of artificial intelligence (AI).
Zephyr integrates AI with extensive datasets discover new therapies, applications for existing therapeutics, and advanced biomarkers for individualized treatments.
The company is co-founded by Yisroel Brumer, PhD, formerly of the Office of the Secretary of Defense; Grant Verstandig, former CEO of Rally Health; and Jeff Sherman, former machine learning architect at Rally Health.